ROSE.SW
Zur Rose Group AG [ROSE.SW] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
ROSE.SW Stock Summary
In the News
ROSE.SW Financial details
Company Rating
-
Market Cap
404.49M
Income
-49.06M
Revenue
1.32B
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
2.28K
Optionable
No
Shortable
Yes
Earnings
17 Aug 2023
P/E
-2.21
Forward P/E
-
PEG
0.3
P/S
0.25
P/B
1.08
P/C
-
P/FCF
-2.58
Quick Ratio
0.65
Current Ratio
1.64
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-6.07
EPS next Y
-
EPS next Q
-
EPS this Y
-32.14%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
20.93%
Revenue last 5Y
5.91%
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-16%
ROE
-41%
ROC
-0.2%
Gross Margin
15%
Oper. Margin
-10%
Profit Margin
-11%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
23.02-122.2
52W High
-
52W Low
-
RSI
-
Rel Volume
-
Avg Volume
94.94K
Volume
-
Perf Week
-
Perf Month
-
Perf Quarter
-
Perf Half Y
-
-
-
-
-
Beta
0.74468
-
-
Volatility
0.95%, 0.95%
Prev Close
-
Price
-
Change
-
Company Profile
- Volume Average 94.94K
- Market Capitalization 404.49M
- Employee 2.28K
- CEO Mr. Walter Hess
- Headquarters Frauenfeld,CH
- IPO Date 2017-07-06
-
Website
https://www.zurrosegroup.com 
Zur Rose Group AG operates an e-commerce pharmacy and a wholesale business for medical and pharmaceutical products under the Zur Rose and DocMorris brands in Germany, Switzerland, and rest of Europe. It offers consumer health, beauty, and personal care products. The company also provides medicines management services. It operates stationary pharmacy shops. The company sells its products directly to physicians, online mail-order pharmacies, and private individuals. The company was formerly known as Zur Rose AG and changed its name to Zur Rose Group AG in May 2015. Zur Rose Group AG was founded in 1993 and is headquartered in Frauenfeld, Switzerland.
